182 related articles for article (PubMed ID: 36405105)
21. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
22. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
23. Perioperative Transjugular Intrahepatic Portosystemic Shunt Is Associated With Decreased Postoperative Complications in Decompensated Cirrhotics Undergoing Abdominal Surgery.
Aryan M; McPhail J; Ravi S; Harris P; Allamneni C; Shoreibah M
Am Surg; 2022 Jul; 88(7):1613-1620. PubMed ID: 35113676
[TBL] [Abstract][Full Text] [Related]
24. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
[TBL] [Abstract][Full Text] [Related]
25. Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding.
Kumar R; Kerbert AJC; Sheikh MF; Roth N; Calvao JAF; Mesquita MD; Barreira AI; Gurm HS; Ramsahye K; Mookerjee RP; Yu D; Davies NH; Mehta G; Agarwal B; Patch D; Jalan R
J Hepatol; 2021 Jan; 74(1):66-79. PubMed ID: 32561318
[TBL] [Abstract][Full Text] [Related]
26. Assessment of Clinical Outcomes, Clinical Manifestations, and Risk Factors for Hepatic Infarction After Transjugular Intrahepatic Portosystemic Shunt Placement (TIPS): A Retrospective Comparative Study.
Tuifua TS; Partovi S; Remer EM; Ragheb J; Bullen JA; Kattan MW; Kapoor B
Cardiovasc Intervent Radiol; 2022 Oct; 45(10):1512-1523. PubMed ID: 35851823
[TBL] [Abstract][Full Text] [Related]
27. Survival benefit of TIPS versus serial paracentesis in patients with refractory ascites: a single institution case-control propensity score analysis.
Gaba RC; Parvinian A; Casadaban LC; Couture PM; Zivin SP; Lakhoo J; Minocha J; Ray CE; Knuttinen MG; Bui JT
Clin Radiol; 2015 May; 70(5):e51-7. PubMed ID: 25758602
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
Kraglund F; Jepsen P; Amanavicius N; Aagaard NK
Scand J Gastroenterol; 2019 Jul; 54(7):899-904. PubMed ID: 31203699
[No Abstract] [Full Text] [Related]
29. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
30. Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt.
Ferral H; Bjarnason H; Wegryn SA; Rengel GJ; Nazarian GK; Rank JM; Tadavarthy SM; Hunter DW; Castaneda-Zuniga WR
Radiology; 1993 Dec; 189(3):795-801. PubMed ID: 8234706
[TBL] [Abstract][Full Text] [Related]
31. Transjugular intrahepatic portosystemic shunt. Experiences at a liver transplantation center.
Hidajat N; Vogl T; Stobbe H; Schmidt J; Wex C; Lenzen R; Berg T; Neuhaus P; Felix R
Acta Radiol; 2000 Sep; 41(5):474-8. PubMed ID: 11016769
[TBL] [Abstract][Full Text] [Related]
32. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome.
Zhou CZ; Wang RF; Lv WF; Fu YQ; Cheng DL; Zhu YJ; Hou CL; Ye XJ
World J Gastroenterol; 2020 Jun; 26(24):3472-3483. PubMed ID: 32655270
[TBL] [Abstract][Full Text] [Related]
33. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
Saad WE; Darwish WM; Davies MG; Waldman DL
J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
[TBL] [Abstract][Full Text] [Related]
34. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.
Salerno F; Cammà C; Enea M; Rössle M; Wong F
Gastroenterology; 2007 Sep; 133(3):825-34. PubMed ID: 17678653
[TBL] [Abstract][Full Text] [Related]
35. Elective Surgery but not Transjugular Intrahepatic Portosystemic Shunt Precipitates Acute-On-Chronic Liver Failure.
Chang J; Bamarni A; Böhling N; Zhou X; Klein LM; Meinke J; Duerr GD; Lingohr P; Wehner S; Brol MJ; Rockstroh JK; Kalff JC; Manekeller S; Meyer C; Spengler U; Jansen C; Arroyo V; Strassburg CP; Trebicka J; Praktiknjo M
Hepatol Commun; 2021 Jul; 5(7):1265-1277. PubMed ID: 34278174
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement.
Allegretti AS; Frenk NE; Li DK; Seethapathy H; Vela Parada XF; Long J; Endres P; Pratt DS; Chung RT; Ganguli S; Irani Z; Yamada K
PLoS One; 2019; 14(5):e0217442. PubMed ID: 31120995
[TBL] [Abstract][Full Text] [Related]
37. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
[TBL] [Abstract][Full Text] [Related]
38. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
39. A Standardized Assessment of Functional Disability Predicts 1-year Mortality in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory Ascites.
Grunwald D; Tapper EB; Jiang ZG; Ahmed M; Malik R
J Clin Gastroenterol; 2016 Jan; 50(1):75-9. PubMed ID: 25984975
[TBL] [Abstract][Full Text] [Related]
40. Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.
Praktiknjo M; Abu-Omar J; Chang J; Thomas D; Jansen C; Kupczyk P; Schepis F; Garcia-Pagan JC; Merli M; Meyer C; Strassburg CP; Pieper CC; Trebicka J
JHEP Rep; 2021 Jun; 3(3):100264. PubMed ID: 34013182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
